Viral Vector Development Service Market Analysis & Forecast 2024-2030

Viral Vector Development Service Market by Product Type ( Retroviral Vectors, Lentiviral Vectors, Adenoviral Vectors, Adeno-associated Viral Vectors, vaccinia vector, herpes simplex victor, baculovirus vector) by Application / End User (Pharmaceutical Manufacturers, Biotechnology Companies, Research Institutes) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)

Report Code: PSMR- 75          Category: Biotechnology           Region :  Global         Report Format :                  

 Request Free Sample


    ×

     Table of Contents

    Global Viral Vector Development Service Market is expected to reach USD 4483.35 million by 2030 with CAGR of 19.2% between 2024 and 2030

    Viral vector is gene transfer therapy use to manipulate and modify specific cell type or tissue. It is most effective gene manipulation technique used globally. Various virus types are use in Viral vector process to provide either transient or permanent gene delivery to cells. Viral vector process based on virus included are:

    • Retroviral Vectors - Retroviruses are stably integrate their genomes into host cell chromosomes. These viruses are positive strand RNA viruses and can enter virtually any mammalian cell type. Retroviruses can carry foreign genes of around 8 kb.
    • Lentiviral Vectors - Lentiviruses are a subgroup of the retrovirus family and allow stable, long-term expression into the host cell genome.
    • Adenoviral Vectors - Adenoviruses are DNA viruses can transiently transduce nearly any mammalian cell type. The adenovirus enters target cells by binding to the Coxsackie/Adenovirus receptor (CAR) . The packaging capacity of adenoviruses is 7–8 kb.
    • Adeno-associated Viral Vectors - Adeno-associated viruses are capable of transducing a broad range of dividing and non-dividing cells types, with a helper virus like adenovirus or herpes virus to produce recombinant virions in packaging cells. Adeno-associated viruses have packaging capacity of up to 4.9 kb.
    • Other Viral Vectors - Other viral vector systems based on vaccinia virus, herpes simplex virus, baculovirus.

    Viral Vector Development Service Market

    Viral Vectors technique relies completely on viruses . The choice of virus for Viral Vectors process depend on :

    • Safety: Pathogenic viruses are used occasionally to create viral vectors, they are modified in specific way to minimize handling risk.
    • Low toxicity: The viral vector should have as minimal as possible effect on tissue or cell it infects. It has vital importance in studies requiring gene delivery in vivo as immune response will get developed in organism against foreign cell body.
    • Stability: Some viruses are genetically unstable and can rapidly rearrange their genomes. Hence unstable vectors are usually avoided in Viral Vectors process.
    • Cell type specificity: Most viral vectors are constructed to infect as wide a range of cell types as possible and sometimes the opposite is preferred.
    • Selection: Viral vectors should contain selectable properties like resistance to a certain antibiotic, so that the cells that have taken up the viral vector can be isolated.

    Viral Vector Development Service Market : End User/Application

    • Pharmaceutical Manufacturers
    • Biotechnology Companies
    • Research Institutes

    Viral Vector Development Service Market : Product Type

    • Retroviral Vectors
    • Lentiviral Vectors
    • Adenoviral Vectors
    • Adeno-associated Viral Vectors
    • Other Viral Vectors

    Viral Vector Development Service Market : Competition Analysis

    This reports covers in-depth analysis of major players of Viral Vector Development Service Market. Competition Analysis included in study covers Company Profile, Products, Services and Solutions, Viral Vector Development Service Revenue (Value), Recent Developments . Some of key players in market are:
    • Kaneka Eurogentec
    • FinVector
    • Brammer Bio
    • Cell and Gene Therapy Catapult
    • FUJIFILM Diosynth Biotechnologies
    • Sanofi
    • Spark Therapeutics
    • Cobra Biologics
    • UniQure and MassBiologics
    • Renova Therapeutics
    • Shenzhen SiBiono GeneTech
    • Thermo Fisher Scientific

    Global Viral Vector Development Service Market: Regional Analysis

    • North America
      • U.S.A
      • Canada
    • Europe
      • France
      • Germany
      • Spain
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South East Asia
    • Latin America
      • Brazil
    • Middle East and Africa

    Global Viral Vector Development Service Market Report delivers a comprehensive analysis of the following parameters:

    • Market Forecast for 2024-2030
    • Market growth drivers
    • Challenges and Opportunities
    • Emerging and Current market trends
    • Market player Capacity, Production, Revenue (Value)
    • Supply (Production), Consumption, Export, Import analysis
    • End user/application Analysis

    Report Coverage

    Parameters Details

    Base Year

    2023

    Historical Data

    2018-2023

    Forecast Data

    2024-2030

    Base Year Value (2023)

    USD 1311.2 million

    Forecast Value (2030)

    USD 4483.35 million

    CAGR (2022 to 2028)

    19.2 %

    Regional Scope

    North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW


    Frequently Asked Questions (FAQ)


    Viral Vector Development Service Market was valued at around USD 1311.2 million in 2023 & estimated to reach USD 4483.35 million by 2030.




    Viral Vector Development Service Market is likely to grow at compounded annual growth rate (CAGR) of 19.2% between 2024 to 2030.












    Yes, the report includes COVID 19 impact on the market.



    Purchase Options

      Online Access $2450

      PDF Access $3550

      PDF + Dashboard $4050
        Access

    Inquire Before Buying

    Please fill below details:

      ×
      Free Customization

      We are committed to offering 100 % free customization while purchasing.



        Access the FREE Sample

        Receive a detailed insight into the Viral Vector Development Service Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.

         Request Free Sample


          ×